01-01-1970 12:00 AM | Source: Reuters
Novartis fourth-quarter sales, core net income trail analyst expectations
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
ZURICH - Novartis's fourth-quarter sales and profit rose less than analysts expected, as the Swiss drugmaker said on Tuesday that the COVID-19 pandemic affected divisions including opthalmology, dermatology and its generics unit.
Core net income in the final three months of 2020 rose 3% in constant currencies to $3.03 billion, compared to the average forecast of $3.15 billion in a Refinitiv poll of analysts. Sales rose 1% to $12.77 billion, compared to $12.88 billion forecast in the poll.
Latest News
Hold Grasim Industries Ltd For Target Rs. 2,777 By C...
Buy Bharat Dynamics Ltd For Target Rs. 1445 By Choic...
Sagarmanthan maritime meet kicks off in Delhi on Monday
Indian economy capable of handling global shocks: RB...
India has become a market that you can`t ignore: Glo...
Market Outlook By Dr. Vikas Gupta, CEO and Chief Inv...
Goods traffic doubles on the new railway freight cor...
Tata seals deal with Pegatron for iPhone plant in In...
Tomato prices drop 22.5 pc as flow of fresh crop pic...
India clocks 12 pc rise in deal volume in Jan-Oct, C...
